Virus-like Particle Vaccines and Platforms for Vaccine Development
Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human papillomavirus, and hepatitis E virus—has been approved; they are very efficacious and offer long-lasting immune re...
| Auteurs principaux: | , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
MDPI AG
2023-05-01
|
| Collection: | Viruses |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/1999-4915/15/5/1109 |